Loading clinical trials...
Loading clinical trials...
The VicTor Study is a randomized, double blind, placebo-controlled, 3-period, multiple-dose crossover study in participants with OSA.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Apnimed
NCT06498648 · Advanced Dedifferentiated Liposarcoma, Advanced Leiomyosarcoma, and more
NCT07575867 · Atrial Fibrillation, Stroke Prevention in Patients With Atrial Fibrillation, and more
NCT05872204 · Low Grade Serous Ovarian Carcinoma, Adult Type Granulosa Cell Tumor
NCT04333537 · Buccal Mucosa Squamous Cell Carcinoma, Floor of Mouth Squamous Cell Carcinoma, and more
NCT03429036 · Hearing Disorder, Oral Mucosal Disease, and more
Santa Monica Clinical Trials
Los Angeles, California
Brigham and Women's Hospital
Boston, Massachusetts
Clayton Sleep Institute
St Louis, Missouri
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions